We cannot, however, currently exclude the possibility that anti-cancer activity of the complexes may be exerted without the complexes entering the cells, for example by the complexes transiently interacting with kinases located at the cell membrane (e.g. receptor tyrosine kinases) affecting downstream phospho-signalling. The gene discussed is NTRK1; the disease is cancer.